1. Home
  2. STKH vs CNSP Comparison

STKH vs CNSP Comparison

Compare STKH & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • CNSP
  • Stock Information
  • Founded
  • STKH 2018
  • CNSP 2017
  • Country
  • STKH Israel
  • CNSP United States
  • Employees
  • STKH N/A
  • CNSP N/A
  • Industry
  • STKH Packaged Foods
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • CNSP Health Care
  • Exchange
  • STKH Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • STKH 4.9M
  • CNSP 5.6M
  • IPO Year
  • STKH 2021
  • CNSP 2019
  • Fundamental
  • Price
  • STKH $0.97
  • CNSP $1.25
  • Analyst Decision
  • STKH
  • CNSP Hold
  • Analyst Count
  • STKH 0
  • CNSP 1
  • Target Price
  • STKH N/A
  • CNSP N/A
  • AVG Volume (30 Days)
  • STKH 15.6K
  • CNSP 332.7K
  • Earning Date
  • STKH 03-31-2025
  • CNSP 05-14-2025
  • Dividend Yield
  • STKH N/A
  • CNSP N/A
  • EPS Growth
  • STKH N/A
  • CNSP N/A
  • EPS
  • STKH N/A
  • CNSP N/A
  • Revenue
  • STKH $10,000.00
  • CNSP N/A
  • Revenue This Year
  • STKH N/A
  • CNSP N/A
  • Revenue Next Year
  • STKH N/A
  • CNSP N/A
  • P/E Ratio
  • STKH N/A
  • CNSP N/A
  • Revenue Growth
  • STKH N/A
  • CNSP N/A
  • 52 Week Low
  • STKH $0.92
  • CNSP $1.21
  • 52 Week High
  • STKH $5.50
  • CNSP $800.00
  • Technical
  • Relative Strength Index (RSI)
  • STKH 26.95
  • CNSP 30.28
  • Support Level
  • STKH $0.92
  • CNSP $1.28
  • Resistance Level
  • STKH $1.14
  • CNSP $1.46
  • Average True Range (ATR)
  • STKH 0.10
  • CNSP 0.38
  • MACD
  • STKH -0.01
  • CNSP -0.12
  • Stochastic Oscillator
  • STKH 12.26
  • CNSP 1.18

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: